Order Article Reprints

Parent P, Auclin E, Patrikidou A, Mezquita L, Martínez Chanzá N, Dumont C, Rodriguez-Vida A, Llacer C, Lozano R, Ratta R, et al. Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma. Cancers. 2023; 15(4):1066. https://doi.org/10.3390/cancers15041066

Parent, Pauline, Edouard Auclin, Anna Patrikidou, Laura Mezquita, Nieves Martínez Chanzá, Clément Dumont, Alejo Rodriguez-Vida, Casilda Llacer, Rebeca Lozano, Raffaele Ratta, and et al. 2023. "Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma" Cancers 15, no. 4: 1066. https://doi.org/10.3390/cancers15041066

Parent, P., Auclin, E., Patrikidou, A., Mezquita, L., Martínez Chanzá, N., Dumont, C., Rodriguez-Vida, A., Llacer, C., Lozano, R., Ratta, R., Merseburger, A. S., Sternberg, C. N., Baciarello, G., Colomba, E., Fuerea, A., Besse, B., Loriot, Y., & Lavaud, P. (2023). Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma. Cancers, 15(4), 1066. https://doi.org/10.3390/cancers15041066